製品の概要

  • 製品名Anti-NDP antibody
    NDP 一次抗体 製品一覧
  • 製品の詳細
    Rabbit polyclonal to NDP
  • アプリケーション適用あり: WB, ICCmore details
  • 種交差性
    交差種: Human
  • 免疫原

    An 18 amino acid synthetic peptide from near the N-terminus of Human NDP (NP_000257).

  • ポジティブ・コントロール
    • Jurkat cell lysate; Jurkat cells

製品の特性

アプリケーション

Our Abpromise guarantee covers the use of ab106381 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

アプリケーション Abreviews 特記事項
WB Use a concentration of 1 - 2 µg/ml. Predicted molecular weight: 15 kDa.
ICC Use a concentration of 5 µg/ml.

ターゲット情報

  • 機能Activates the canonical Wnt signaling pathway through FZD4 and LRP5 coreceptor. Plays a central role in retinal vascularization by acting as a ligand for FZD4 that signals via stabilizing beta-catenin (CTNNB1) and activating LEF/TCF-mediated transcriptional programs. Acts in concert with TSPAN12 to activate FZD4 independently of the Wnt-dependent activation of FZD4, suggesting the existence of a Wnt-independent signaling that also promote accumulation the beta-catenin (CTNNB1). May be involved in a pathway that regulates neural cell differentiation and proliferation. Possible role in neuroectodermal cell-cell interaction.
  • 組織特異性Expressed in the outer nuclear, inner nuclear and ganglion cell layers of the retina, and in fetal and adult brain.
  • 関連疾患Defects in NDP are the cause of Norrie disease (ND) [MIM:310600]; also known as atrophia bulborum hereditaria or Episkopi blindness. ND is a recessive disorder characterized by very early childhood blindness due to degenerative and proliferative changes of the neuroretina. Approximately 50% of patients show some form of progressive mental disorder, often with psychotic features, and about one-third of patients develop sensorineural deafness in the second decade. In addition, some patients have more complex phenotypes, including growth failure and seizure.
    Defects in NDP are the cause of vitreoretinopathy exudative type 2 (EVR2) [MIM:305390]. EVR2 is a disorder of the retinal vasculature characterized by an abrupt cessation of growth of peripheral capillaries, leading to an avascular peripheral retina. This may lead to compensatory retinal neovascularization, which is thought to be induced by hypoxia from the initial avascular insult. New vessels are prone to leakage and rupture causing exudates and bleeding, followed by scarring, retinal detachment and blindness. Clinical features can be highly variable, even within the same family. Patients with mild forms of the disease are asymptomatic, and their only disease related abnormality is an arc of avascular retina in the extreme temporal periphery.
  • 配列類似性Contains 1 CTCK (C-terminal cystine knot-like) domain.
  • 細胞内局在Secreted.
  • Information by UniProt
  • 参照データベース
  • 別名
    • EVR2 antibody
    • Exudative vitreoretinopathy 2 (X linked) antibody
    • FEVR antibody
    • ND antibody
    • NDP antibody
    • NDP_HUMAN antibody
    • Norrie disease (pseudoglioma) antibody
    • Norrie disease protein antibody
    • Norrin antibody
    • Norrin precursor antibody
    • X linked exudative vitreoretinopathy 2 protein antibody
    • X-linked exudative vitreoretinopathy 2 protein antibody
    see all

Anti-NDP antibody 画像

  • Lane 1 : Anti-NDP antibody (ab106381) at 1 µg/ml
    Lane 2 : Anti-NDP antibody (ab106381) at 2 µg/ml

    Lane 1 : Jurkat cell lysate
    Lane 2 : Jurkat cell lysate

    Lysates/proteins at 15 µg per lane.


    Predicted band size : 15 kDa
  • ab106381, at 5 µg/ml, staining NDP in Jurkat cells by Immunocytochemistry.

Anti-NDP antibody (ab106381) 使用論文

ab106381 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab106381.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"